Wegovy® (semaglutide) is a once-weekly GLP-1 injection that curbs appetite and slows digestion to support meaningful, lasting weight loss. Prescribed online by licensed physicians and shipped to your door.
Brand-name semaglutide · Once-weekly injectable
Wegovy® is the brand name for semaglutide prescribed specifically for chronic weight management. It is a GLP-1 receptor agonist — it mimics a natural gut hormone (glucagon-like peptide-1) that signals fullness, slows how quickly the stomach empties, and helps regulate appetite and blood sugar.
Wegovy® was the higher-dose semaglutide approved by the FDA for weight management in adults in 2021, and later for adolescents aged 12 and older. It is the most-prescribed GLP-1 weight-loss medication and is made by Novo Nordisk.
Wegovy® mimics the natural hormone GLP-1, which your gut releases after eating. By amplifying that signal, it changes how hungry you feel and how your body handles food.
Wegovy® acts on hunger centers in the brain so you feel less hungry and more satisfied with smaller portions.
It slows the rate at which your stomach empties, helping you stay full longer after meals and reducing snacking.
Semaglutide improves insulin response and helps smooth out blood-sugar swings that can drive cravings.
In eligible adults, Wegovy® is also FDA-approved to lower the risk of major cardiovascular events like heart attack and stroke.
Both formats deliver the same FDA-approved semaglutide in the same doses. The difference is the device and how it's paid for. Your physician will help you choose.
The classic Wegovy® prefilled, single-use auto-injector pen containing one weekly dose. Simple click-and-inject design with no separate needle to manage — the most flexible payment option.
A single-dose vial administered with a separate needle and syringe, available cash-pay through NovoCare®. Often the most affordable way to access brand-name Wegovy® without insurance.
Choose the pen if:
You want the simplest experience, no separate needle, and you're using insurance coverage.
Choose the vial if:
You're paying cash and want the lowest price, and you're comfortable drawing a dose with a syringe.
Wegovy® is titrated slowly over about four months to help your body adjust and minimize side effects. You start low, and your physician increases the dose roughly every four weeks, as tolerated.
The 0.25 mg starting dose is for beginning treatment, not for weight management on its own. The target maintenance dose is 2.4 mg, but your physician may keep you at a lower dose if it's effective and better tolerated, and may slow the schedule based on how you respond. Always follow your prescriber's instructions.
Wegovy® was studied in large, multi-week clinical trials. These are the headline results — individual outcomes vary.
In the 68-week STEP 1 trial, adults without diabetes lost an average of about 15% of their body weight on the 2.4 mg dose when Wegovy® was combined with a reduced-calorie diet and increased physical activity — far more than diet and exercise alone.
Beyond weight management, Wegovy® is FDA-approved to reduce the risk of major cardiovascular events — such as cardiovascular death, heart attack, and stroke — in adults with established cardiovascular disease who have obesity or overweight.
* Based on the STEP 1 pivotal clinical trial. Results combine medication with diet and exercise. Individual results vary based on dose, adherence, and health history.
Wegovy® is the most-prescribed GLP-1 approved specifically for weight loss. Here's how it lines up against other common options.
| Feature | Wegovy® | Zepbound® | Ozempic® | Saxenda® |
|---|---|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide | Semaglutide | Liraglutide |
| Drug class | GLP-1 agonist | GLP-1 + GIP dual | GLP-1 agonist | GLP-1 agonist |
| Primary FDA use | Weight management | Weight management | Type 2 diabetes | Weight management |
| Administration | Weekly injection | Weekly injection | Weekly injection | Daily injection |
| Avg. weight loss | ~15% | Up to ~21% | Not its indication | ~8% |
| Also approved for | Cardiovascular risk | Sleep apnea (OSA) | CV risk (in diabetes) | Adolescents 12+ |
| Brand maker | Novo Nordisk | Eli Lilly | Novo Nordisk | Novo Nordisk |
Average weight-loss figures are based on pivotal clinical trials and differ by medication, dose, and population. Ozempic® is not FDA-approved for weight loss. Your physician will recommend the most appropriate option for you.
There are two main paths to access Wegovy®. Our care team works directly with your insurer to help you navigate coverage wherever possible.
A prescription is only part of the picture. Your program wraps the medication in ongoing clinical care and support to help you succeed.
If you qualify, your physician prescribes Wegovy® in the format and dose that fits you.
Secure telemedicine evaluations and follow-ups with licensed providers — no waiting rooms.
Guidance on titration and managing common side effects, with a team you can message.
Coordinators check coverage, apply savings programs, and lay out cash-pay options.
Track weight, doses, and milestones so you and your provider can see what's working.
Medication ships from a licensed pharmacy directly to your door, refilled on schedule.
Our telemedicine process is fast, private, and designed to take you from consultation to prescription as smoothly as possible.
Tell us about your medical history and weight journey to see if you medically qualify — no cost, no obligation.
A licensed physician reviews your assessment, BMI, and goals via a secure telemedicine visit.
If Wegovy® is appropriate, your physician issues your prescription and chooses the right format and dose.
Your medication ships from a licensed pharmacy to your door, with ongoing monthly clinical support included.
Eligibility is always determined by a licensed physician during your clinical evaluation. These are the general guidelines.
Take the free quiz and our care team will help you understand your options — no commitment required.
Clinical trials paired the medication with diet and activity for a reason. These habits help protect muscle, ease side effects, and support lasting results.
Aim for protein at each meal to help preserve muscle while you lose fat, and to stay satisfied on a smaller appetite.
Combine regular movement with strength training. Resistance work is especially important for maintaining lean mass.
Plenty of water and fiber-rich foods help manage common digestive side effects like constipation.
Consistent, quality sleep supports appetite regulation and recovery — and complements the medication's effects.
Ongoing check-ins and community make the journey feel less isolating and help you stay consistent.
Build habits you can keep. Lasting results come from pairing medication with sustainable lifestyle change.
Most patients tolerate Wegovy® well. Side effects are typically mild, most common at the start of treatment or after dose increases, and improve as your body adjusts.
Most common at the start or after dose increases. Usually mild and eases within a few weeks. Smaller meals help.
Changes in GI motility are common. Staying hydrated and keeping up fiber intake helps manage symptoms.
Bloating, fullness, or mild abdominal pain — especially after eating. Typically resolves as your body adjusts.
An intended effect of the medication. Ensure you're still meeting your nutritional and protein needs.
Usually dose-related. Physicians titrate the dose gradually to minimize this. Report persistent symptoms.
Mild redness or swelling at the site. Rotating injection sites helps. Resolves quickly in most cases.
Rapid weight loss can raise gallstone risk. Report severe upper-abdominal pain, fever, or jaundice promptly.
Very rare but serious. Stop the medication and contact your physician immediately if you have severe, persistent abdominal pain.
Important: Wegovy® carries a boxed warning regarding the risk of thyroid C-cell tumors. This is a general overview and not a complete list of side effects or warnings. Your physician will review your full health history and explain all relevant risks during your evaluation. Always follow your physician's dosing instructions and report unusual symptoms promptly. Read full Important Safety Information →
A few simple practices keep your medication effective and your injections comfortable. Always follow the instructions that come with your prescription.
Store Wegovy® in the refrigerator until you're ready to use it. Do not freeze it — discard any medication that has frozen.
If needed, an unused pen can be kept at room temperature for a limited time per the label. Check your product's instructions.
Inject into the abdomen, thigh, or upper arm, rotating the site each week to reduce irritation. Inject on the same day weekly.
Place used pens, vials, and needles in an FDA-cleared sharps container — never loose in household trash.
If your next dose is more than 2 days away, take the missed dose; if it's sooner, skip it. Don't double up — ask your provider.
Reach your care team about severe or persistent side effects, signs of an allergic reaction, or questions about your dose.
Fast Medical Weight Loss pairs FDA-approved medication with real clinical oversight and a process built around you.
Every prescription is evaluated and issued by a licensed provider — never an automated checkout.
Nationwide telemedicine access, with visits conducted by secure video or questionnaire.
Medication ships from licensed pharmacies straight to your door in plain packaging.
Your health information is protected at every step of your care.
Clear cash-pay rates plus insurance support — no surprise fees, cancel anytime.
A care team for dosing questions, side effects, and refills throughout your journey.
All-inclusive programs — licensed-physician visits and your medication included. No membership fees, cancel anytime. Multi-month plans save you more.
The 3-month and 6-month plans are billed once and are discounted versus the monthly rate. All medication requires a licensed-physician evaluation and prescription.
Clear answers to the most common questions about Wegovy®, semaglutide, and our telemedicine program.
Both contain semaglutide. Ozempic® is FDA-approved for type 2 diabetes and uses lower doses. Wegovy® is FDA-approved specifically for weight management and goes up to a higher 2.4 mg maintenance dose designed for obesity treatment.
Wegovy® targets one hormone receptor (GLP-1); Zepbound® targets two (GLP-1 and GIP). Zepbound® showed greater average weight loss in trials (up to ~21% vs ~15%), but the right choice depends on your health profile, tolerance, and cost.
The single-dose pen is the simplest option and is insurance-eligible. The vial is a lower-cost cash-pay route through NovoCare® but requires drawing your dose with a syringe. Your physician will recommend the best fit.
Some commercial plans cover Wegovy®, and our coordinators will work with your plan and apply any savings programs. Coverage for weight-loss medication isn't guaranteed; if it's not covered, cash-pay options are available.
Most patients notice reduced appetite within the first 1–2 weeks. Meaningful weight loss typically becomes visible at 4–8 weeks, with maximum results usually seen over 12–18 months of consistent treatment at the maintenance dose.
Research suggests many patients regain weight after stopping, since the medication controls hunger signals. That's why ongoing lifestyle changes alongside treatment matter — your physician will help build a long-term plan.
Wegovy® is FDA-approved for adolescents aged 12 and older with obesity, alongside diet and exercise. A licensed physician will evaluate whether it's appropriate based on the individual's health history.
Evaluations are conducted via secure video or an asynchronous questionnaire, depending on your state and preference. All visits are HIPAA-compliant and conducted by licensed physicians.
Take the free quiz and let a licensed physician determine whether Wegovy® is right for your health profile, goals, and budget.
Start My Free ConsultationWegovy®, Ozempic®, and NovoCare® are registered trademarks of Novo Nordisk A/S. This page has not been reviewed or endorsed by Novo Nordisk. *Average weight-loss figures are from the STEP 1 pivotal clinical trial (2.4 mg dose, 68 weeks) in adults without diabetes who had a BMI ≥ 30, or ≥ 27 with weight-related comorbidities, combined with a reduced-calorie diet and increased physical activity. ‡The $299/month program includes licensed-physician visits and a monthly medication supply, with no membership fees; cancel anytime. The 3-month and 6-month plans are billed once and are discounted versus the monthly rate. Pricing is subject to change. Individual outcomes vary based on dose, adherence, diet, exercise, and health history. This page is for informational purposes only and does not constitute medical advice. All treatment requires a licensed physician evaluation, eligibility, and a prescription; not all patients will qualify. Prescriptions require an online consultation with a healthcare provider who will determine whether a prescription is appropriate. Medication is dispensed through licensed pharmacies, including NovoCare®. ©2025 Fast Medical Weight Loss. HIPAA Compliant. All Rights Reserved.
©2026 All Rights Reserved. fastmedicalweightloss.org
